Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solventbased paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma.

Autor: Hai-ying Wang1, Zhi-hua Yao1, Hong Tang1, Yan Zhao1, Xiao-san Zhang1, Shu-na Yao1, Shu-jun Yang1 yang001shu@163.com, Yan-yan Liu1 liuyanyan4827@yahoo.com
Zdroj: OncoTargets & Therapy. Sep2016, Vol. 9, p5663-5669. 7p.
Databáze: Academic Search Ultimate